Pre-Activity Survey Question Title 1. All of the following are risk factors for C. difficile infection except: Recent use of antimicrobials Older age High fat diet Compromised immunity Question Title 2. High-risk patient populations for CDI recurrence include all of the following except: Infection with hypervirulent 027 strain History of severe CDI Prolonged hospitalization Exposure to children in daycare Question Title 3. Which of the following is not recommended by the IDSA/SHEA guidelines for treatment of a first recurrence of CDI? Metronidazole Vancomycin standard dosing Vancomycin pulse/taper Fidaxomicin Question Title 4. According to the IDSA/SHEA guidelines, appropriate treatment of a second recurrence of CDI in the patient who was previously treated with vancomycin standard dosing can include any of the following except: Vancomycin standard dosing plus IV metronidazole Vancomycin taper/pulse dosing Vancomycin plus rifaximin chaser Fidaxomicin Question Title 5. Compared to vancomycin, the use of fidaxomicin has been shown to result in significantly: Higher overall cure rates Lower cure rates in patients with mild-to-moderate CDI only Lower rates of recurrence Higher rates of recurrence in patients with severe CDI Question Title 6. Which of the following has been demonstrated to reduce the risk of recurrence in a patient with CDI? Regular use of probiotics with standard of care antimicrobial therapy Bezlotoxumab with standard of care antimicrobial therapy Bezlotoxumab with or without standard of care antimicrobial therapy Proton pump inhibitor use with standard of care antimicrobial therapy Done
